CD38 mAb in ASCT Ineligible NDMM
Optimizing Clinical Outcomes With CD38 Antibodies for Transplant-Ineligible Patients With NDMM

Released: June 11, 2024

Expiration: June 10, 2025

Activity

Progress
1
Course Completed